We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Extracorporeal Shock Wave Technology Repairs Osteoarthritis Damage

By HospiMedica International staff writers
Posted on 27 Jun 2011
A novel preclinical study suggests that extracorporeal shock wave technology (ESWT) has chondroprotective effects in the osteoarthritic rat knee.

Researchers at Kaohsiung Chang Gung Memorial Hospital (Taiwan) utilized three groups of Sprague-Dawley rats, each containing nine animals. More...
The rats in the control group did not have their anterior cruciate ligaments (ACL) surgically cut, whereas animals in the other two groups underwent surgical ACL transection (ACLT) in order to induce osteoarthritis (OA). Of the two ACLT groups, one group received a single ESWT procedure immediately following ACLT, while the other group received no treatment of any kind after ACLT. All animals underwent evaluations including radiograph, bone mineral density, serum levels of cartilage oligometric protein and osteocalcin, and urinary concentration of C-telopeptide of type II collagen (CTXII), and histomorphological examination.

The results showed that a single ESWT procedure prevented or significantly improved surgically induced OA damage to the knee in the rat model, significantly decreased articular cartilage degradation, and improved subchondral bone remodeling. When treated with ESWT, the surgically compromised OA knees displayed comparable data to the control group of normal, healthy knees at 12 weeks post-treatment. Multiple analyses of articular cartilage, subchondral bone, and blood and urine protein markers suggest that early application of ESWT provides a chondroprotective effect to prevent OA onset. The study was published on June 9, 2011, in the online edition of Archives of Orthopedic Trauma Surgery.

"Based on these positive study results, ESWT treatment may offer an effective, low-cost treatment option in humans that carries little risk compared with other treatments," said lead author orthopedic surgeon Ching-Jen Wang, MD. "This study is clinically relevant because it validates our original theory that ESWT treatment has a chondroprotective effect that repairs and prevents osteoarthritic changes in the knee joint."

ESWT is a method of treatment for multiple musculoskeletal conditions. Presently it is only approved by the US Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. ESWT probably works due to the microtrauma of the repeated shock wave to the affected area, which creates neovascularization into the area. It is this new blood flow that promotes tissue healing. A second theory is that in chronic pain, the brain has "forgotten" about the pain and is doing nothing to heal the area. By having shockwave therapy, a new inflammatory process is created and the brain can react to it by sending the necessary body nutrients to the area to promote healing.

Related Links:

Kaohsiung Chang Gung Memorial Hospital




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.